Tevogen Bio Inc

Contributing Author

Recent Articles by Tevogen Bio Inc

Jun-30	Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters TVGN GlobeNewswire
Jun-18	Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery TVGN GlobeNewswire
Jun-09	Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives TVGN GlobeNewswire
May-30	Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships TVGN GlobeNewswire
May-23	Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow TVGN GlobeNewswire
May-22	Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting TVGN GlobeNewswire
May-12	Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation TVGN GlobeNewswire
May-02	Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest TVGN GlobeNewswire